Immunic's market cap is currently $98.19M. The company's EPS TTM is $-1.239; its P/E ratio is ―; Immunic is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -111.00K	$ -77.00K	$ -85.00K	$ -39.00K	$ -50.00K
Operating Income	$ -99.22M	$ -119.49M	$ -91.67M	$ -48.97M	$ -37.03M
EBITDA	$ -99.11M	$ -120.33M	$ -92.86M	$ -48.93M	$ -36.98M
Net Income	$ -93.61M	$ -154.30M	$ -92.79M	$ -43.96M	$ -34.83M
Balance Sheet
Cash & Short-Term Investments	$ 46.67M	$ 116.37M	$ 86.86M	$ 127.45M	$ 29.37M
Total Assets	$ 54.30M	$ 127.75M	$ 139.10M	$ 167.86M	$ 65.95M
Total Debt	$ 1.33M	$ 1.56M	$ 584.00K	$ 679.00K	$ 520.00K
Net Debt	$ -45.34M	$ -105.18M	$ -86.28M	$ -126.77M	$ -28.85M
Total Liabilities	$ 25.37M	$ 14.07M	$ 11.98M	$ 9.08M	$ 7.59M
Stockholders' Equity	$ 28.93M	$ 113.68M	$ 127.11M	$ 158.78M	$ 58.36M
Cash Flow
Free Cash Flow	$ -71.16M	$ -65.26M	$ -83.30M	$ -46.27M	$ -28.60M
Operating Cash Flow	$ -70.83M	$ -65.14M	$ -83.23M	$ -46.12M	$ -28.55M
Investing Cash Flow	$ 9.46M	$ -9.74M	$ -67.00K	$ -146.00K	$ 10.54M
Financing Cash Flow	$ 1.03M	$ 95.76K	$ 42.84K	$ 144.43M	$ 34.90M

Currency in USD

Immunic Earnings and Revenue History

Income Statement >

Immunic Debt to Assets

Balance Sheet >

Immunic Cash Flow

Cash Flow >

Immunic Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing